Alterations of fatty acid composition and metabolism in APP/PS1 transgenic mice

Yi-Ran Bai,Ying-Ying Wang,Dong-Li Meng,Zhi-Li Shi,Xiang-Feng Song,Zhong-Zhi Yang,Wei Zhang,Lei Yang,Ru-Ling Shi
DOI: https://doi.org/10.1016/j.neulet.2020.135401
IF: 3.197
2020-11-01
Neuroscience Letters
Abstract:<p>Accumulating evidence suggests that abnormal fatty acid composition is related to the development of Alzheimer's disease (AD). However, there is no consistency in the fatty acid profile and metabolism associated with AD pathogenesis. This study aims to define the characteristics of fatty acid composition and metabolism in AD. Using 6-month-old APP/PS1 transgenic mice with wild-type mice as a control, we examined the serum lipids, brain fatty acid composition, and the expression levels of various genes involved in liver fatty acid β-oxidation. The results of our study demonstrate that APP/PS1 mice present decreased serum free fatty acids, altered brain fatty acid profiles, and minimal change in liver fatty acid β-oxidation. Our results suggest that abnormal fatty acid compositions and contents may play potential roles in AD progression. This study provides further evidence for the metabolic basis of AD pathogenesis.</p>
neurosciences
What problem does this paper attempt to address?
This paper aims to explore the changing characteristics of fatty acid composition and metabolism in Alzheimer's disease (AD). Specifically, the study used 6 - month - old APP/PS1 transgenic mice (a commonly used AD animal model) and wild - type mice as controls. By detecting serum lipids, fatty acid composition in brain tissues and the expression levels of genes related to fatty acid β - oxidation in liver tissues, the fatty acid composition and metabolic characteristics in AD were defined. The main research questions include: 1. **Serum lipid levels**: Compare the levels of total cholesterol (TC), triglycerides (TG) and free fatty acids (FFA) in the serum of APP/PS1 transgenic mice and wild - type mice. 2. **Fatty acid composition in brain tissues**: Analyze the types and relative contents of fatty acids in the cerebral cortex of APP/PS1 transgenic mice and wild - type mice. 3. **Expression of genes related to fatty acid β - oxidation in liver tissues**: Detect the mRNA and protein levels of PPARα, ACOX1 and CPT1 in the liver tissues of APP/PS1 transgenic mice and wild - type mice. The research results show that the serum free fatty acid levels in APP/PS1 transgenic mice are significantly decreased, the fatty acid composition in brain tissues changes, but the gene expression related to fatty acid β - oxidation in liver tissues does not change much. These results suggest that abnormal fatty acid composition and content may play a potential role in the progression of AD, providing further evidence for the metabolic basis of AD.